Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 27, 2019
Simplifying Complex Insulin Regimens While Preserving Good Glycemic Control in Type 2 DiabetesZoltán Taybani, Balázs Bótyik, Mónika Katkó, et al.Endocrinology, Diabetes & Metabolism|December 3, 2022
One-year safety and efficacy results of insulin treatment simplification with IDegLira in type 2 diabetesZoltán J Taybani, Balázs Bótyik, András Gyimesi, et al.Clinical Endocrinology|December 6, 2013
Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjectsHajnalka Lőrincz, Mónika Katkó, Mariann Harangi, et al.Orvosi Hetilap|June 28, 2026
[Towards the elimination of iodine deficiency in Hungary]Zsanett Molnár, Erika Galgóczi, Mónika Katkó, et al.Kidney International|July 1, 2011
Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cellsErzsébet Zavaczki, Viktória Jeney, Anupam Agarwal, et al.VASA. Zeitschrift Fur Gefasskrankheiten|June 13, 2017
Paraoxonase-1 and myeloperoxidase correlate with vascular biomarkers in overweight patients with newly diagnosed untreated hyperlipidaemiaAnita Szentpéteri, Noémi Zsíros, Viktória E Varga, et al.International Journal of Molecular Sciences|November 13, 2025
Protective Effect of Factor XIII Intron-K G Allele on Subclinical Vascular DiseaseBarbara Cogoi, Regina Esze, Sándor Somodi, et al.Biomedicines|February 26, 2025
Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with NeuropathySára Csiha, Marcell Hernyák, Ágnes Molnár, et al.Life (Basel, Switzerland)|July 28, 2026
The Effect of Iatrogenic Hypothyroidism on Lipoprotein Subfractions and Markers of HDL Function in Patients with Differentiated Thyroid CarcinomaMónika Katkó, Annamária Gazdag, Anita Szentpéteri, et al.Clinical Biochemistry|May 1, 2016
Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complicationsNoémi Zsíros, Péter Koncsos, Hajnalka Lőrincz, et al.Pageof 2